Recordati is expecting to sell off its pharmaceutical chemical
operations by the end of next year or early in 2004, according to
the company's chief executive, who expects €80-€90m in proceeds for
The creditors of Australian over-the-counter medicines and vitamins
manufacturer Pan Pharmaceuticals have rejected a rescue bid for the
company at a meeting held last week. Another meeting is due to be
held later today.
Chiron's headquarters is hit by two homemade bombs, with an animal
rights group claiming responsibility. The blasts caused no
casualties and only minor damage to property, but represent an
alarming escalation in the tactics used...
French company Flamel Technologies has added another high-profile
client for its drug delivery technology spurring another leap in
its shares that have already climbed almost 800 per cent over the
last 12 months.
Top pharmaceutical manufacturing plants strive to achieve efficient
operations that result in increased profitability as well as
superior product quality and satisfied customers. These are the
findings of a new study from market research...
DSM reports a disappointing set of second quarter results and says
it is unlikely to meet its 2002 operating profit level this year;
the group blames weaker demand for its products and negative
currency factors. Restructuring drive...
The pharmaceutical industry is failing to increase efficiencies in
core areas of its business - such as clinical trials and sales -
because of an enormous pressure from investors to drive revenues,
according to Datamonitor.
Scotland's PPL has started a mass slaughter of its flock of sheep
engineered to produce alpha-1 antitrypsin in their milk. The cull
could spell the end of the firm's ambitions in transgenic
Caliper Technologies has been given the go-ahead by the US federal
Trade Commission for its $71 million cash and stock acquisition of
Zymark, a specialist in laboratory automation and robotics
There is a growing trend towards patients self-medicating with
over-the-counter products rather than asking their doctors for a
prescription medication, and this promises to benefit companies
involved in pharmaceutical packaging,...
GeneMedix and Penang Development of Malaysia have signed a letter
of intent that will see the two establish a new company in the
latter country's second city, at a cost of $34 million (€29m), for
the development, manufacture...
Transgenic drug production company PPL Therapeutics has been rocked
by a decision by Germany's Bayer to walk away from their protein
development partnership, placing the future of the Scottish firm at
Switzerland's Bachem SA, which specialises in the manufacture and
sale of bulk peptides and related organic chemicals as active
ingredients for the pharmaceutical industry, has announced that it
expects full-year sales growth...
Belgian pharmaceuticals and chemicals group UCB has said it expects
its profit in 2003 to be at a level comparable to those of the
previous year, influenced by the unfavourable economic climate, but
especially affected by the fall...